Supplementary Figures 1-10 from ZNF217 Is a Marker of Poor Prognosis in Breast Cancer That Drives Epithelial–Mesenchymal Transition and Invasion

Authors :: Pascale A. Cohen
Ruth Rimokh
Isabelle Treilleux
Laura Corbo
Pierre Roux
Jean-Luc Coll
Véronique Josserand
Evelyne Grisard
Ivan Bièche
Stéphanie Vinot
Sandra E. Ghayad
Nhan T. Nguyen
Aurélie Thollet
Julie A. Vendrell
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: PDF file - 3.2MB, complementary figures showing the impact of ZNF217 overexpression on MDA-MB-231 and HMLE cells phenotype

Tools